皮下注射-话题@MedSci

#皮下注射#

50篇内容 | 2560人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1372228, encodeId=440313e2228dd, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Lancet：皮下注射甲氨蝶呤治疗中重度斑块型银屑病的强化给药方案, objectType=article, longId=85088, objectId=aef18508830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aef18508830, replyNumber=0, likeNumber=82, createdTime=2016-12-23, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aef18508830, moduleTitle=Lancet：皮下注射甲氨蝶呤治疗中重度斑块型银屑病的强化给药方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aef18508830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372227, encodeId=1dbe13e2227de, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=ECTRIMS 2016：百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta疗效显著优于Avonex（干扰素β-1a）, objectType=article, longId=78356, objectId=ead2e8356ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ead2e8356ce, replyNumber=0, likeNumber=55, createdTime=2016-09-26, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ead2e8356ce, moduleTitle=ECTRIMS 2016：百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta疗效显著优于Avonex（干扰素β-1a）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ead2e8356ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372226, encodeId=f03913e22260f, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=狼疮新药进展！葛兰素史克向美国和欧盟提交皮下注射剂型狼疮药Benlysta（每周一次）上市申请, objectType=article, longId=78353, objectId=b0cde8353c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0cde8353c5, replyNumber=0, likeNumber=70, createdTime=2016-09-26, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0cde8353c5, moduleTitle=狼疮新药进展！葛兰素史克向美国和欧盟提交皮下注射剂型狼疮药Benlysta（每周一次）上市申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0cde8353c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372225, encodeId=f5d413e22255f, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=EHMTIC 2016：诺华每月一次皮下注射药物AMG 334治疗慢性偏头痛显著降低每月偏头痛天数, objectType=article, longId=77929, objectId=90bfe792967, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90bfe792967, replyNumber=0, likeNumber=64, createdTime=2016-09-21, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90bfe792967, moduleTitle=EHMTIC 2016：诺华每月一次皮下注射药物AMG 334治疗慢性偏头痛显著降低每月偏头痛天数, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90bfe792967)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372224, encodeId=f76513e222478, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=喜讯！百健和艾伯维每月一次皮下注射多发性硬化症药物Zinbryta获欧盟批准, objectType=article, longId=72275, objectId=7697e227519, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7697e227519, replyNumber=0, likeNumber=78, createdTime=2016-07-09, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7697e227519, moduleTitle=喜讯！百健和艾伯维每月一次皮下注射多发性硬化症药物Zinbryta获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7697e227519)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372223, encodeId=fab113e222327, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=喜讯！FDA批准百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta, objectType=article, longId=69494, objectId=393e69494f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=393e69494f9, replyNumber=0, likeNumber=75, createdTime=2016-06-01, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=393e69494f9, moduleTitle=喜讯！FDA批准百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=393e69494f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372222, encodeId=427a13e22226b, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=NEJM：麻疹疫苗采用皮下注射方式更优, objectType=article, longId=49623, objectId=e41349623ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e41349623ba, replyNumber=0, likeNumber=62, createdTime=2015-04-22, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e41349623ba, moduleTitle=NEJM：麻疹疫苗采用皮下注射方式更优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e41349623ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372221, encodeId=926913e22217c, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=CHMP建议批准罗氏皮下注射剂型RoACTEMRA, objectType=article, longId=28635, objectId=eafc28635ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eafc28635ec, replyNumber=0, likeNumber=83, createdTime=2013-12-28, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eafc28635ec, moduleTitle=CHMP建议批准罗氏皮下注射剂型RoACTEMRA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eafc28635ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372220, encodeId=757013e2220eb, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=CHMP建议批准罗氏皮下注射剂型Herceptin用于HER2阳性乳腺癌, objectType=article, longId=20872, objectId=597b208e219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597b208e219, replyNumber=0, likeNumber=81, createdTime=2013-07-05, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597b208e219, moduleTitle=CHMP建议批准罗氏皮下注射剂型Herceptin用于HER2阳性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=597b208e219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372219, encodeId=180413e2219b1, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=FDA批准高三尖杉酯碱皮下注射剂上市, objectType=article, longId=10656, objectId=40fc1065667, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40fc1065667, replyNumber=0, likeNumber=67, createdTime=2012-11-01, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40fc1065667, moduleTitle=FDA批准高三尖杉酯碱皮下注射剂上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40fc1065667)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372218, encodeId=22f813e221824, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=罗氏（Roche）公布Herceptin皮下注射剂型III期研究数据, objectType=article, longId=5761, objectId=6ea85e6117, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ea85e6117, replyNumber=0, likeNumber=76, createdTime=2012-04-27, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ea85e6117, moduleTitle=罗氏（Roche）公布Herceptin皮下注射剂型III期研究数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ea85e6117)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

皮下注射

2020-05-29

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Lancet：皮下注射甲氨蝶呤治疗中重度斑块型银屑病的强化给药方案

2016-12-23

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

ECTRIMS 2016：百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta疗效显著优于Avonex（干扰素β-1a）

2016-09-26

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

狼疮新药进展！葛兰素史克向美国和欧盟提交皮下注射剂型狼疮药Benlysta（每周一次）上市申请

2016-09-26

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

EHMTIC 2016：诺华每月一次皮下注射药物AMG 334治疗慢性偏头痛显著降低每月偏头痛天数

2016-09-21

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

喜讯！百健和艾伯维每月一次皮下注射多发性硬化症药物Zinbryta获欧盟批准

2016-07-09

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

喜讯！FDA批准百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta

2016-06-01

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

NEJM：麻疹疫苗采用皮下注射方式更优

2015-04-22

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

CHMP建议批准罗氏皮下注射剂型RoACTEMRA

2013-12-28

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

CHMP建议批准罗氏皮下注射剂型Herceptin用于HER2阳性乳腺癌

2013-07-05

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

FDA批准高三尖杉酯碱皮下注射剂上市

2012-11-01

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

罗氏（Roche）公布Herceptin皮下注射剂型III期研究数据

2012-04-27

科室
- - 订阅+
  - 更多科室
工具
服务